Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,140,904
+$926,875 QoQ
Shares Held
158,117
-22.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#112
of 625 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,140,904 | 158,117 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,214,029 | 202,676 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,408,231 | 196,406 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $982,688 | 92,012 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,040,125 | 107,451 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,069,508 | 743,419 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,899,871 | 529,482 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $4,762 | 276,732 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $4,332,116 | 209,281 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,231,908 | 171,910 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $3,541,422 | 245,591 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $5,263,187 | 303,179 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,215,642 | 394,793 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $6,214,054 | 264,203 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $12,742,839 | 456,242 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $9,682,405 | 413,778 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $20,562,660 | 609,264 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $11,465,143 | 328,232 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $10,278,031 | 337,538 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $9,700,363 | 295,833 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $5,733,210 | 189,465 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||